The Vitamin D analog 1α,25-Dihydroxy-2β-(3-Hydroxypropyloxy) Vitamin D 3 (Eldecalcitol) is a potent regulator of calcium and phosphate metabolism

Calcified Tissue International

Volumn 89, Issue 5, 2011, Pages 372-378

  Brown, Alex J ^a   Ritter, Cynthia S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Intestinal mineral absorption; Mineral and electrolyte metabolism; PTH PTHrP; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM ION; ELDECALCITOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; VANILLOID RECEPTOR 6; VITAMIN D BINDING PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM ABSORPTION; CALCIUM EXCRETION; CALCIUM METABOLISM; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENCY; DRUG PROTEIN BINDING; FEMALE; INTESTINE ABSORPTION; METABOLIC REGULATION; NONHUMAN; PHOSPHATE ABSORPTION; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URINARY EXCRETION;

ANIMALS; CALCITRIOL; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENUM; FEMALE; FIBROBLAST GROWTH FACTORS; PHOSPHATES; RATS; TRPV CATION CHANNELS; VITAMIN D;

EID: 82755189460     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9528-7     Document Type: Article

References (20)

1. Matsumoto T, Kubodera N (2007) ED-71, a new active vitamin D3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects. J Steroid Biochem Mol Biol 103(3-5):584-586 (Pubitemid 46401355)
2. Okano T, Tsugawa N, Masuda S, Takeuchi A, Kobayashi T, Nishii Y (1991) A novel synthetic vitamin D3 analogue, 2-beta- (3-hydroxypropoxy)-calcitriol (ED-71): its biological activities and pharmacological effects on calcium metabolism. Contrib Nephrol 91:116-122
3. Tsurukami H, Nakamura T, Suzuki K, Sato K, Higuchi Y, Nishii Y (1994) A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy) 1alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcif Tissue Int 54(2):142-149 (Pubitemid 24046725)
4. Uchiyama Y, Higuchi Y, Takeda S, Masaki T, Shira-Ishi A, Sato K, Kubodera N, Ikeda K, Ogata E (2002) ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 30:582-588 (Pubitemid 34270495)
5. Matsumoto T, Miki T, Hagino H, Sugimoto T, Okamoto S, Hirota T, Tanigawara Y, Hayashi Y, Fukunaga M, Shiraki M, Nakamura T (2005) A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab 90(9):5031-5036 (Pubitemid 41262250)
6. Okano T, Tsugawa N, Masuda S, Takeuchi A, Kobayashi T, Takita Y, Nishii Y (1989) Regulatory activities of 2beta-(3-hydroxypropoxy)- 1alpha, 25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolism. Biochem Biophys Res Commun 163(3):1444-1449 (Pubitemid 19244750)
7. Hatakeyama S, Nagashima S, Imai N, Takahashi K, Ishihara J, Sugita A, Nihei T, Saito H, Takahashi F, Kubodera N (2007) Synthesis and biological evaluation of a 3-position epimer of 1alpha, 25-dihydroxy-2beta-(3- hydroxypropoxy)vitamin D3 (ED- 71). J Steroid Biochem Mol Biol 103(3-5):222-226 (Pubitemid 46401295)
8. Flanagan JN, Zheng S, Chiang KC, Kittaka A, Sakaki T, Nakabayashi S, Zhao X, Spanjaard RA, Persons KS, Mathieu JS, Holick MF, Chen TC (2009) Evaluation of 19-nor-2alpha-(3- hydroxypropyl)-1alpha, 25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer. Anticancer Res 29(9):3547-3553
9. Saito N, Suhara Y, Abe D, Kusudo T, Ohta M, Yasuda K, Sakaki T, Honzawa S, Fujishima T, Kittaka A (2009) Synthesis of 2alpha-propoxy-1alpha, 25-dihydroxyvitamin D3 and comparison of its metabolism by human CYP24A1 and rat CYP24A1. Bioorg Med Chem 17(13):4296-4301
10. Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E (1992) Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1, 25-(OH)2D3. J Bone Miner Res 7(7):835-839
11. Kollenkirchen U, Fox J, Walters MR (1991) Normocalcemia without hyperparathyroidism in vitamin D-deficient rats. J Bone Miner Res 6(3):273-278
12. Brown AJ, Finch J, Grieff M, Ritter C, Kubodera N, Nishii Y, Slatopolsky E (1993) The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 133(3):1158-1164 (Pubitemid 23267767)
13. Brown AJ, Ritter CS, Holliday LS, Knutson JC, Strugnell SA (2004) Tissue distribution and activity studies of 1,24-dihydroxyvitamin D2, a metabolite of vitamin D2 with low calcemic activity in vivo. Biochem Pharmacol 68(7):1289-1296 (Pubitemid 39179388)
14. Brown AJ, Finch JL, Takahashi F, Slatopolsky E (2000) The calcemic activity of 19-nor-1,25(OH)2D2 decreases with duration of treatment. J Am Soc Nephrol 11:2088-2094
15. Mizobuchi M, Ritter CS, Krits I, Slatopolsky E, Sicard G, Brown AJ (2009) Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res 24(7):1173-1179
16. Harada S, Takeda S, Uno A, Takahashi F, Saito H (2010) Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo. J Steroid Biochem Mol Biol 121(1-2):281-283
17. Slatopolsky E, Finch J, Ritter C, Takahashi F (1998) Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats. Am J Kidney Dis 32(Suppl 2):S40-S47 (Pubitemid 28487834)
18. Brown AJ, Finch J, Slatopolsky E (2002) Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphate transport. J Lab Clin Med 139:279-284 (Pubitemid 34577479)
19. Halloran BP, De Luca HF (1981) Intestinal calcium transport: evidence for two distinct mechanisms of action of 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 208(2):477-486 (Pubitemid 11035132)
20. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 98(23):13324-13329 (Pubitemid 33051361)